Keywords
Postmenopause
Therapy
Cardiovascular risk
How to Cite
Abstract
Climacteric and postmenopause are life stages marked by profound hormonal changes that significantly impact women’s health, particularly regarding cardiovascular risk. This review discusses the main pharmacological and integrative strategies for managing symptoms during this period, highlighting hormone therapy (HT) in its different formulations, herbal medicine, integrative practices such as yoga and acupuncture, and cognitive behavioral therapy (CBT). The benefits and risks of HT are examined, especially when initiated within the so-called “window of opportunity,” as well as non-hormonal alternatives for patients with contraindications or personal preferences. Recent evidence indicates that the severity of vasomotor symptoms and the timing of treatment initiation directly influence cardiovascular outcomes, emphasizing the importance of individualized approaches. In conclusion, clinical management in postmenopause should address not only symptom relief but also the prevention of adverse cardiovascular events, combining pharmacological and non-pharmacological strategies to enhance women’s quality of life in this stage.
References
FEBRASGO. Manual de Orientação em Climatério. São Paulo: FEBRASGO; 2010. Disponível em: ttps://docs.bvsalud.org/biblioref/2020/03/1052419/manual_climaterio-2010.pdf. Acesso em: 15 set. 2025.
Nilsson S, Henriksson M, Hammar M, et al. A 2-year follow-up to a randomized controlled trial on resistance training in postmenopausal women: vasomotor symptoms, quality of life and cardiovascular risk markers. BMC Womens Health. 2024;24:511.
doi:10.1186/s12905-024-03351-1.
Lobo RA, Kaunitz AM, Santoro N, Bernick B, Graham S, Mirkin S. Metabolic and cardiovascular effects of TX-001HR in menopausal women with vasomotor symptoms. Climacteric. 2019;22(6):610-616. doi:10.1080/13697137.2019.1640197.
Deecher D, Dorries K. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Arch Womens Ment Health. 2007;10:247-257. doi:10.1007/s00737-007-0209-5.
Kaczmarczyk M, Deuter CE, Deus H, et al. Effects of separate and combined estradiol and progesterone administration on fear extinction in healthy pre-menopausal women. Transl Psychiatry. 2024;14:449. doi:10.1038/s41398-024-03079-4.
Rodrigues MAH, Reis ZSN, Verona APA, Teixeira MC, Pappa GL, Soares Junior JM, et al. Climacteric women's perspectives on menopause and hormone therapy: Knowledge gaps, fears, and the role of healthcare advice. PLoS One. 2025;20(5):e0316873. doi:10.1371/journal.pone.0316873.
Farquhar D. Postmenopausal hormone replacement therapy for chronic disease prevention: results from the Women's Health Initiative trial. CMAJ. 2002;167(4):377-378. PMID:12197697.
Stute P, Marsden J, Salih N, Cagnacci A. Reappraising 21 years of the WHI study: Putting the findings in context for clinical practice. Maturitas. 2023;174:8-13.doi:10.1016/j.maturitas.2023.04.271.
Writing Group for the Women's Health Initiative Investigators. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial. JAMA. 2002;288(3):321-333. doi:10.1001/jama.288.3.321.
FDA. FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women [Internet]. Silver Spring (MD): FDA; 2025. Disponível em: https://www.fda.gov/patients/fda-expert-panels/fda-expert-panel-menopause-and-hormone-replacement-therapy-women-07172025. Acesso em: 15 set. 2025.
Rocha BMA, Pereira MSV, Carneiro JQ. Terapias complementares: fitoterapia como opção terapêutica no climatério e menopausa. Rev Ciênc Saúde Nova Esperança. 2018;16(1):16-25. doi:10.17695/issn.2317-7160.v16n1a2018p16-25
Costa FM da, Carvalho AS de. A utilização de fitoterápicos no manejo de mulheres na menopausa e climatério. Revista Ibero-Americana de Humanidades, Ciências e Educação-REASE. 2023;9(11):128-142. doi:10.51891/rease.v9i11.1246
Sá IM de. "Fito-hormônios": ciência e natureza no tratamento do climatério. Physis [Internet]. 2012;22(4):1503–22. Available from: https://doi.org/10.1590/S0103-73312012000400013
Esteves EA, Monteiro JBR. Efeitos benéficos das isoflavonas de soja em doencas crônicas. Rev Nutr [Internet]. 2001Jan;14(1):43–52. Available from: https://doi.org/10.1590/S1415-52732001000100007
Sena VMGM, Costa LOBF, Costa HLFF. Efeitos da isoflavona de soja sobre os sintomas climatéricos e espessura endometrial: ensaio clínico, randomizado duplo-cego e controlado. Rev Bras Ginecol Obstet [Internet]. 2007Oct;29(10):532–7. Available from: https://doi.org/10.1590/S0100-72032007001000007
Hunter MS. Cognitive behavioral therapy for menopausal symptoms. Climacteric. 2021 Feb;24(1):51-56. DOI: 10.1080/13697137.2020.1777965
Almeida MJS , Peixoto C, Ribeiro TTSB, Silva LM, Veras AB. Terapia cognitivo-comportamental em grupo para a disfunção sexual na pós-menopausa. J bras psiquiatr [Internet]. 2018Oct;67(4):231–8. Available from: https://doi.org/10.1590/0047-2085000000210
Netto JRC, Gorayeb R. Descrição de uma intervenção psicológica com mulheres no climatério. Paidéia (Ribeirão Preto) [Internet]. 2005May;15(31):277–85. Available from: https://doi.org/10.1590/S0103-863X2005000200015
Sobral BABFN, Silva RA, Souza CFQ, Abrão FMS, Costa AM. Benefícios das Práticas Integrativas e Complementares em Saúde na qualidade de vida e nos sintomas de mulheres no climatério: uma revisão sistemática. Saúde em Debate. 2024;48(Especial 2):e9321. doi:10.1590/2358-28982024E29321P
Jorge MP, Santaella DF, Pontes IMO, Shiramizu VKM, Nascimento EB, Cabral A, Lemos TMAM, Silva RH, Ribeiro AM. Hatha Yoga practice decreases menopause symptoms and improves quality of life: a randomized controlled trial. Complement Ther Med. 2016 Jun;26:128-35. doi:10.1016/j.ctim.2016.03.014
Dornella AH, Hashimoto ES. Entre Guerreiras e Cinderelas: contribuições da terapia cognitivo comportamental na superação dos desafios encontrados na meia-idade feminina [comunicação oral]. Apresentado no: Congresso Multidisciplinar; 2024; Apucarana, PR. Faculdade de Apucarana
Freitas ER, Barbosa AJG. Qualidade de vida e bem-estar psicológico no climatério. Arquivos Brasileiros de Psicologia. 2015;67(3). Disponível em: https://pepsic.bvsalud.org/scielo.php?script=sci_arttext&pid=S1809-52672015000300009 Accesso em 23/09/2025
Bala S, Komarraju SL, Dasarathan S, Muralidharan S. Effect of health-promoting behaviors and menopausal symptoms of urban women of Hyderabad: a randomized controlled trial. Journal of Biological Methods [Internet]. 2024;11(3):e99010028. doi:10.14440/jbm.2024.0041
Hunter MS. Cognitive behavioral therapy for menopausal symptoms. Climacteric. 2021;24(1):51-56. doi:10.1080/13697137.2020.1777965
Xia W, Khalil RA. Hormone Replacement Therapy and Cardiovascular Health in Postmenopausal Women. Int J Mol Sci. 2025;26:5078. doi:10.3390/ijms26115078.
Allison MA, Manson JE. The complex interplay of vasomotor symptoms, hormone therapy, and cardiovascular risk. Menopause. 2009;16(4):619-620. doi:10.1097/gme.0b013e3181aa30ff.
El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD, et al. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. Circulation. 2020;142(25):e506-e532. doi:10.1161/CIR.0000000000000912.
. Luo X, Wang Y, Wang L, Shen Y, Ren M. Association Between Female Androgen Levels, Metabolic Syndrome, and Cardiovascular Disease: An NHANES Analysis (2013-2016). Int J Womens Health. 2024;16:2087-2101. doi:10.2147/IJWH.S475149.
Nilsson S, Qvick A, Henriksson M, Lawesson SS, Holm AS, Leander K. Menopausal Vasomotor Symptoms and Subclinical Atherosclerotic Cardiovascular Disease: A Population-Based Study. J Am Heart Assoc. 2024;13(17):e033648. doi:10.1161/JAHA.123.033648.
Thurston RC, Aslanidou Vlachos HE, Derby CA, Jackson EA, Brooks MM, Matthews KA, et al. Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN. J Am Heart Assoc. 2021;10(3):e017416. doi:10.1161/JAHA.120.017416.
Liu Q, Si F, Liu Z, Wu Y, Yu J. Association between triglyceride-glucose index and risk of cardiovascular disease among postmenopausal women. Cardiovasc Diabetol. 2023;22(1):21. doi:10.1186/s12933-023-01753-3.
Cagnacci A, Cannoletta M, Palma F, Zanin R, Xholli A, Volpe A. Menopausal symptoms and risk factors for cardiovascular disease in postmenopause. Climacteric. 2012;15(2):157-162. doi:10.3109/13697137.2011.617852.
Gu Y, Han F, Xue M, et al. The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis. BMC Womens Health. 2024;24:60. doi:10.1186/s12905-023-02788-0.
This work is licensed under a Creative Commons Attribution 4.0 International License.